Shareholders' Equity (Tables)

3 Months Ended

Jul. 29, 2023

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Stock Buyback Activity Under Share Buyback Program

The following table summarizes the Company’s stock buyback activity under this share buyback program:

	Three Months Ended
(in millions, except share and per share data)	July 29, 2023		July 30, 2022
Shares purchased		—		317,635
Average price per share	$	—	$	37.43
Total cost	$	—	$	11.9

Summary of Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax

A summary of changes in AOCI, net of tax is shown below:

	Three Months Ended July 29, 2023
(in millions)	Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(19.8	)	$	0.8		$	(19.0	)
Other comprehensive income (loss)		(2.7	)		(2.2	)		(4.9	)
Tax (expense) benefit		0.2			0.6			0.8
Net other comprehensive income (loss)		(2.5	)		(1.6	)		(4.1	)
Balance at the end of period	$	(22.3	)	$	(0.8	)	$	(23.1	)

	Three Months Ended July 30, 2022
(in millions)	Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(10.9	)		2.0			(8.9	)
Tax (expense) benefit		—			(0.5	)		(0.5	)
Net other comprehensive income (loss)		(10.9	)		1.5			(9.4	)
Balance at the end of period	$	(41.4	)	$	5.2		$	(36.2	)

Summary of RSA and RSU Activity

The following table summarizes RSA activity:

	Restricted stock awards		Weighted average grant date fair value
Non-vested at April 29, 2023		933,674	$	28.73
Awarded		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Non-vested at July 29, 2023		933,674	$	28.73

The following table summarizes RSU activity:

	Restricted stock units			Weighted average grant date fair value
Non-vested at April 29, 2023		727,467		$	30.60
Awarded		—		$	—
Vested		—		$	—
Forfeited		(6,852	)	$	41.87
Non-vested at July 29, 2023		720,615		$	30.49

Summary of Awards Granted to Non-employee Directors

The following table summarizes awards granted to non-employee directors:

	Non-employee director awards			Deferred non-employee director awards		Total			Weighted average grant date fair value
Outstanding at April 29, 2023		—			45,750		45,750		$	40.56
Awarded		16,804			29,729		46,533		$	33.32
Issued		(16,804	)		—		(16,804	)	$	33.32
Outstanding at July 29, 2023		—			75,479		75,479		$	37.31

Summary of combined stock option activity and related information for stock options granted

The following table summarizes stock option activity:

	Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 29, 2023		20,000	$	37.01		1.2	$	0.1
Exercised		—	$	—
Forfeited		—	$	—
Outstanding and exercisable at July 29, 2023		20,000	$	37.01		0.9	$	0.0

Summary of Stock-based Compensation Expense Related to Equity Awards

The table below summarizes the stock-based compensation expense related to the equity awards:

	Three Months Ended
(in millions)	July 29, 2023		July 30, 2022
RSUs	$	1.0	$	2.4
Deferred non-employee director awards		1.0		1.0
Non-employee director awards		0.6		0.6
Total stock-based compensation expense	$	2.6	$	4.0